Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Ampio Pharmaceuticals, Inc.

AMEX: AMPEHealthcare / Biotechnology / USA
0.55-0.08-12.70%Vol 1 388 5311Y Perf -64.63%
Dec 10th, 2018 11:47
BID0.55 ASK0.55
Open0.63 Previous Close0.63
Pre-Market- After-Trading0.63
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)59 
Earnings Rating
Buy
Price Range Ratio 52wk %
4.35 
Earnings Date
11th Dec 2018

Today's Price Range

0.550.63

 

52wk Range

0.354.95

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
5.00%
3 Months
18.87%
6 Months
-66.84%
1 Year
-64.63%
3 Years
-81.47%
5 Years
-91.10%

Quotes

Name / TickerPriceChg.Chg.%
AMPE0.55-0.0800-12.70
AAPL165.05-3.4400-2.04
GOOG1 036.50-0.0800-0.01
MSFT105.000.18000.17
XOM75.18-2.4600-3.17
WFC48.70-1.5600-3.10
JNJ143.15-2.2800-1.57
FB140.573.15002.29
GE6.86-0.1500-2.14
JPM100.15-3.1400-3.04
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.00
Current Ratio
5.30
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
30.35
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-5.30
Cash Flow Per Share
-0.15
Price to Tangible Book
30.35
Book Value per Share
0.02
Enterprise Value (in ths.)
59 221
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-119.86
ROE last 12 Months
-1 046.95
Return on Assets (5Y Avg)
-264.40
ROA last 12 Months
-85.46
Return on Capital (5Y Avg)
-79.89
ROC last 12 Months
-1 046.95
Return on invested Capital Q
-240.60
Return on invested Capital Y
-87.95
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.10-
Q01 2016--0.13-
Q04 2015--0.19-
Q03 2015--0.14-
Q02 2015--0.14-
Q01 2015--0.14-
Q03 2014-0.17-0.18-5.88
Q02 2014-0.24-0.1729.17
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Dec 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 388 531
Shares Outstanding (in ths.)106 720
Trades Count2 018
Dollar Volume842 481
Avg. Volume1 491 154
Avg. Weekly Volume2 453 675
Avg. Monthly Volume1 499 269
Avg. Quarterly Volume1 564 425

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

25%75%

Bearish Bullish

65%35%

Bearish Bullish

87%13%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News